4.4 Article

Human germline nuclear transfer to overcome mitochondrial disease and failed fertilization after ICSI

期刊

出版社

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10815-022-02401-7

关键词

Pronuclear transfer; Spindle transfer; Mitochondrial DNA disease; Female infertility; Fertilization failure

资金

  1. China Scholarship Council (CSC) [201506160059]
  2. Special Research Fund from Ghent University (Bijzonder Onderzoeksfonds, BOF) [01SC2916, 01SC9518]
  3. Ferring Pharmaceuticals
  4. FWO-Vlaanderen (Flemish fund for scientific research) [G051017N, G051516N, G1507816N, 11C2821N, 1S80222N]

向作者/读者索取更多资源

This study aims to explore the application of human nuclear transfer (NT) in treating mitochondrial disease transmission and failed fertilization. The experiments confirmed the effectiveness of NT in reducing mitochondrial transmission and demonstrated for the first time that NT can enable successful fertilization in cases of failed fertilization.
Purpose Providing additional insights on the efficacy of human nuclear transfer (NT). Here, and earlier, NT has been applied to minimize transmission risk of mitochondrial DNA (mtDNA) diseases. NT has also been proposed for treating infertility, but it is still unclear which infertility indications would benefit. In this work, we therefore additionally assess the applicability of NT to overcome failed fertilization. Methods Patient 1 carries a homoplasmic mtDNA mutation (m.11778G > A). Seventeen metaphase II (MII) oocytes underwent pre-implantation genetic testing (PGT), while five MII oocytes were used for spindle transfer (ST), and one in vitro matured (IVM) metaphase I oocyte underwent early pronuclear transfer (ePNT). Patients 2-3 experienced multiple failed intracytoplasmic sperm injection (ICSI) and ICSI-assisted oocyte activation (AOA) cycles. For these patients, the obtained MII oocytes underwent an additional ICSI-AOA cycle, while the IVM oocytes were subjected to ST. Results For patient 1, PGT-M confirmed mutation loads close to 100%. All ST-reconstructed oocytes fertilized and cleaved, of which one progressed to the blastocyst stage. The reconstructed ePNT-zygote reached the morula stage. These samples showed an average mtDNA carry-over rate of 2.9% +/- 0.8%, confirming the feasibility of NT to reduce mtDNA transmission. For patient 2-3 displaying fertilization failure, ST resulted in, respectively, 4/5 and 6/6 fertilized oocytes, providing evidence, for the first time, that NT can enable successful fertilization in this patient population. Conclusion Our study showcases the repertoire of disorders for which NT can be beneficial, to overcome either mitochondrial disease transmission or failed fertilization after ICSI-AOA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据